ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AYTU BioPharma Inc

AYTU BioPharma Inc (AYTU)

1,665
-0,025
(-1,48%)
Beim Schlusskurs: 06 Februar 10:00PM
1,665
0,00
( 0,00% )
Nach Börsenschluss: 10:23PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,665
Gebot
1,42
Fragen
1,80
Volumen
22.902
1,64 Tagesbereich 1,72
1,3001 52-Wochen-Bereich 3,45
Marktkapitalisierung
Handelsende
1,69
Handelsbeginn
1,71
Letzte Trade
6
@
1.6888
Letzter Handelszeitpunkt
22:49:15
Finanzvolumen
US$ 38.787
VWAP
1,6936
Durchschnittliches Volumen (3 Mio.)
32.160
Ausgegebene Aktien
6.149.369
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,64
Gewinn pro Aktie (EPS)
-2,58
Erlöse
81M
Nettogewinn
-15,84M

Über AYTU BioPharma Inc

Aytu BioPharma is a pharmaceutical company focused on commercializing novel therapeutics. The company's prescription products include Adzenys XR-ODT(R) (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT(R) (met... Aytu BioPharma is a pharmaceutical company focused on commercializing novel therapeutics. The company's prescription products include Adzenys XR-ODT(R) (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT(R) (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), Karbinal(R) ER (carbinoxamine maleate), an extended-release antihistamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor(R) and Tri-Vi-Flor(R), two complementary fluoride-based prescription vitamin product lines available in various formulations for infants and children with fluoride deficiency. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
AYTU BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AYTU. The last closing price for AYTU BioPharma was US$1,69. Over the last year, AYTU BioPharma shares have traded in a share price range of US$ 1,3001 to US$ 3,45.

AYTU BioPharma currently has 6.149.369 shares in issue. The market capitalisation of AYTU BioPharma is US$10,39 million. AYTU BioPharma has a price to earnings ratio (PE ratio) of -0.64.

AYTU Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0553.416149068321.611.711.54118481.65779802CS
4-0.115-6.46067415731.781.931.54192871.68904335CS
12-0.055-3.19767441861.721.941.3001321601.60763752CS
26-0.815-32.86290322582.482.851.3001279681.92228926CS
52-0.815-32.86290322582.483.451.3001249342.38027819CS
156-23.935-93.4960937525.6291.30013442157.94334667CS
260-12.581-88.312508774414.246235.2861.3001217192134.77447028CS

AYTU - Frequently Asked Questions (FAQ)

What is the current AYTU BioPharma share price?
The current share price of AYTU BioPharma is US$ 1,665
How many AYTU BioPharma shares are in issue?
AYTU BioPharma has 6.149.369 shares in issue
What is the market cap of AYTU BioPharma?
The market capitalisation of AYTU BioPharma is USD 10,39M
What is the 1 year trading range for AYTU BioPharma share price?
AYTU BioPharma has traded in the range of US$ 1,3001 to US$ 3,45 during the past year
What is the PE ratio of AYTU BioPharma?
The price to earnings ratio of AYTU BioPharma is -0,64
What is the cash to sales ratio of AYTU BioPharma?
The cash to sales ratio of AYTU BioPharma is 0,13
What is the reporting currency for AYTU BioPharma?
AYTU BioPharma reports financial results in USD
What is the latest annual turnover for AYTU BioPharma?
The latest annual turnover of AYTU BioPharma is USD 81M
What is the latest annual profit for AYTU BioPharma?
The latest annual profit of AYTU BioPharma is USD -15,84M
What is the registered address of AYTU BioPharma?
The registered address for AYTU BioPharma is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AYTU BioPharma website address?
The website address for AYTU BioPharma is www.aytubio.com
Which industry sector does AYTU BioPharma operate in?
AYTU BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
LTRYLottery com Inc
US$ 2,10
(48,94%)
10,27M
NCEWNew Century Logistics BVI Ltd
US$ 2,57
(35,26%)
1,7M
MGOLMGO Global Inc
US$ 0,24
(29,73%)
26,19M
LPCNLipocine Inc
US$ 4,75
(25,66%)
237
FARMFarmer Brothers Company
US$ 2,20
(22,22%)
103,28k
NKLANikola Corporation
US$ 0,581
(-22,79%)
4,32M
STIMNeuronetics Inc
US$ 2,7975
(-21,42%)
202,87k
WBTNWEBTOON Entertainment Inc
US$ 10,95
(-18,83%)
13,16k
RNXTRenovoRx Inc
US$ 1,20
(-17,81%)
39,39k
LESLLeslies Inc
US$ 1,97
(-12,05%)
209,26k
MGOLMGO Global Inc
US$ 0,24
(29,73%)
26,19M
AMZNAmazon.com Inc
US$ 226,87
(-5,01%)
12,84M
LTRYLottery com Inc
US$ 2,10
(48,94%)
10,27M
RIMEAlgorhythm Holdings Inc
US$ 0,0209
(-1,88%)
7,86M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1286
(-6,13%)
6,21M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock